Fortress Biotech, Inc.
FBIO
$1.82
-$0.03-1.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 56.78M | 56.68M | 62.50M | 63.36M | 65.64M |
| Total Other Revenue | 1.00M | 1.00M | 19.00M | 19.26M | 19.47M |
| Total Revenue | 57.78M | 57.68M | 81.50M | 82.62M | 85.11M |
| Cost of Revenue | 54.85M | 76.96M | 81.11M | 93.15M | 113.85M |
| Gross Profit | 2.94M | -19.29M | 393.00K | -10.53M | -28.74M |
| SG&A Expenses | 91.65M | 83.93M | 77.08M | 76.82M | 80.44M |
| Depreciation & Amortization | 4.49M | 4.24M | 4.58M | 4.58M | 4.58M |
| Other Operating Expenses | -4.55M | -4.55M | -- | -- | -- |
| Total Operating Expenses | 146.44M | 160.58M | 162.77M | 174.56M | 198.87M |
| Operating Income | -88.65M | -102.90M | -81.27M | -91.93M | -113.76M |
| Income Before Tax | -106.12M | -120.45M | -123.08M | -107.04M | -137.51M |
| Income Tax Expenses | 405.00K | 405.00K | 448.00K | 520.00K | 520.00K |
| Earnings from Continuing Operations | -106.52 | -120.86 | -123.53 | -107.56 | -138.03 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 65.36M | 74.86M | 75.01M | 66.87M | 83.52M |
| Net Income | -41.16M | -46.00M | -48.51M | -40.69M | -54.52M |
| EBIT | -88.65M | -102.90M | -81.27M | -91.93M | -113.76M |
| EBITDA | -84.19M | -98.44M | -76.74M | -87.17M | -108.48M |
| EPS Basic | -2.34 | -2.90 | -3.58 | -3.76 | -6.68 |
| Normalized Basic EPS | 0.15 | 0.15 | 1.27 | -0.38 | -0.25 |
| EPS Diluted | -2.34 | -2.90 | -3.58 | -3.76 | -6.68 |
| Normalized Diluted EPS | 0.15 | 0.15 | 1.27 | -0.38 | -0.25 |
| Average Basic Shares Outstanding | 90.48M | 81.18M | 65.92M | 53.72M | 42.78M |
| Average Diluted Shares Outstanding | 90.48M | 81.18M | 65.92M | 53.72M | 42.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -4.88% | -8.73% | -12.42% | -19.74% | -14.73% |